NIH Funding Opportunities (Notices, PA, RFA)

Subscribe to NIH Funding Opportunities (Notices, PA, RFA) feed
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 53 min 44 sec ago

Notice of Extension of PAR-19-189, "Pilot Services Research Grants Not Involving Clinical Trials (R34 Clinical Trial Not Allowed)"

Mon, 2021-10-25 12:09
Notice NOT-MH-22-035 from the NIH Guide for Grants and Contracts

Request for Information (RFI): Seeking Input on Technology Needs for Cancer Control and Population Sciences Researchers

Mon, 2021-10-25 04:28
Notice NOT-CA-22-004 from the NIH Guide for Grants and Contracts

Modifications to the NIMH Special Council Review Procedures

Fri, 2021-10-22 12:30
Notice NOT-MH-22-030 from the NIH Guide for Grants and Contracts

Special Emphasis Notice (SEN): AHRQ Announces Interest in Supporting Primary Care Research Career Development Awards

Fri, 2021-10-22 02:35
Notice NOT-HS-22-002 from the NIH Guide for Grants and Contracts

Notice of High Priority Research Areas for NIDA T32 Training Grants

Thu, 2021-10-21 11:58
Notice NOT-DA-21-087 from the NIH Guide for Grants and Contracts

Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)

Thu, 2021-10-21 07:38
Funding Opportunity PAR-22-049 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) will support extramural research to investigate and mitigate challenges facing clinical assay development and subsequent analytical validation due to preanalytical variability in tumor tissue biopsies, blood biospecimens utilized as liquid biopsies", or other biospecimens as described in this FOA. Extramural research funded under this FOA may include investigations of preanalytical variability associated with the procurement and study of small biopsies (core biopsies, small excision samples), blood utilized for "liquid biopsies", tissue swabs, tissue secretions, pleural and esophageal aspirates, feces, or bodily fluids like sweat, urine, CSF, breast milk and saliva. Investigator-designed experiments will explore how different biospecimen preanalytical conditions affect emerging and clinically relevant biomarkers quantified by a variety of testing platforms. The results from this research program will improve the understanding of how analytical quantification of clinically relevant biomarkers is affected by variation in biospecimen collection, processing, and storage procedures. The overall goal is to expedite biomarker clinical assay development through evidence-based standardization of biopsy handling practices.

Large Health Services Research Demonstration and Dissemination Projects for Combating Antibiotic-Resistant Bacteria (CARB)(R18)

Thu, 2021-10-21 07:24
Funding Opportunity PA-22-048 from the NIH Guide for Grants and Contracts. Demonstration and Dissemination Projects (R18) focused on Combating Antibiotic-Resistant Bacteria (CARB)

Large Research Projects for Combating Antibiotic-Resistant Bacteria (CARB) (R01)

Thu, 2021-10-21 07:22
Funding Opportunity PA-22-047 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for grant funding to conduct Large Research Projects (R01) focused on Combating Antibiotic-Resistant Bacteria (CARB) .

Flexibility Available to Lasker Clinical Research Scholars Affected by COVID-19

Wed, 2021-10-20 12:32
Notice NOT-OD-22-007 from the NIH Guide for Grants and Contracts

Pages